Mandate

Vinge assists NAXS in connection with change of listing to NASDAQ OMX Stockholm

June 01, 2010

NAXS Nordic Access Buyout Fund AB (publ) commenced operations in 2007 and is a company investing in buyout funds with a Nordic focus. The objective is to make the Nordic private equity market accessible to a broader range of investors, which are also offered liquidity through NAXS’s listed shares. The shares have been listed on NASDAQ OMX First North since May 2007 and the admittance to trading of the NAXS share on NASDAQ OMX Stockholm has now been approved by the NASDAQ OMX Stockholm’s Listing Committee. The first day of trading for NAXS’s shares on NASDAQ OMX Stockholm is expected to be Monday, 7 June 2010 and the last day of trading on NASDAQ OMX First North is expected to be Friday, 4 June 2010.

Vinge’s team has primarily consisted of Göran Nyström, Jesper Schönbeck and Emil Hedberg.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026